The decision, made public on Thursday, concludes that Apple's latest implementation of pulse-oximetry functionality falls outside the scope of Masimo's asserted rights. The full ITC commission ...

A fresh ruling keeps the dispute alive, but Apple’s workaround means the Apple Watch can carry on as usual ...

Apple's current blood oxygen sensing implementation in the U.S. does not infringe on patents owned by Masimo and Apple will not face a revived import ban, a U.S. International Trade Commission judge ...

Garmin is intensifying its research into metabolic health with a newly published patent for non-invasive HbA1c estimation. The USPTO filing—granted in early February—describes a system that uses the ...

A federal jury in California ruled Friday that Apple must pay medical device maker Masimo $634 million for infringing a patent on blood oxygen-monitoring technology. Reuters reports the jury found ...

Masimo Corp. ((MASI)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...

“According to Masimo, the CBP ‘inexplicably reversed course’ from its prior rulings in finding that Apple could overcome the LEO by shipping its smartwatches separately from iPhones.” On Wednesday, ...

In early 2024, Apple removed a blood oxygen monitoring feature from its then-current Apple Watch Series 9 and Ultra 2 watches, following a ruling that the feature violated light-based pulse oximetry ...

The company said it would issue a software update to restart the technology, which was caught up in a patent dispute. By Tripp Mickle Reporting from San Francisco Apple said on Thursday that it would ...

Apple removed blood oxygen monitoring from the Apple Watch in early 2024. Somebody has to blink for it to return, and it looks like neither Masimo nor Apple are going to budge. Blood oxygen monitoring ...